The global advanced wound care management market was valued at US$ 9,384.8 million in 2016 and is expected to witness a robust CAGR of 6.8% over the forecast period (2017–2025).
North America held the dominant position in the global market, owing to increasing prevalence of pressure ulcers. According to the National Center for Health Statistics, in 2015, over US$ 13 billion was spent on pressure ulcer management. Furthermore, National Institute of Health and CDC estimated that as of 2015, in the U.S alone, around 2.5 million pressure ulcers were cured.
Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/1159
Asia Pacific is an emerging region in the advanced wound care management market. This is owing to increasing number of global players tapping in the region. For instance, in January 2016, Avita Medical and INDEE Medical signed a distribution agreement for ReCell Device — a medical device used in conjunction with conventional treatments for burns and reconstructive procedures — in Japan. In January 2015, Mundipharma started distribution of Medifoam (also known as BETAplast in South East Asia) in South Asian markets such as Malaysia, Thailand, and Vietnam including China and South Korea. Furthermore, in February 2014, ConvaTec, introduced its revolutionary Aquacel Ag+ wound dressings in European Union, Canada, Hong Kong, and Malaysia. Also, in the same year, ConvaTec started operations in India to up bring novel healthcare technologies and treatment measures in Asian market. Also, in 2012, Smith & Nephew launched 23 new wound care products in Asian market.
Prominent players in the global advanced wound care management market include, Johnson & Johnson, 3M Company, Baxter International, Acelity, Coloplast, Integra Lifesciences, Kinetic Concepts, Medtronic plc, Smith & Nephew plc, Leap Therapeutics, Hematris Wound Care, and Triage Meditech.
Advanced wound care products are used by healthcare practitioners. It is a therapeutic approach for encouraging effective wound healing process. Advanced wound care management treatment uses moisture therapy, which provides moist microenvironment that stimulates the natural healing process. The products used in moist wound care includes film and foam dressings, hydrogels, alginates, and hydrocolloids. This therapy besides maintaining hydrated environment, also keeps the temperature consistent, allows flow of oxygen, removes dead tissue, protects the site from exogenous infection, and eases the pain associated with dressing changes.
Growth of the advanced wound care management market is primarily driven by increasing incidence of diabetes coupled with chronic wounds and increasing geriatric population. According to Centers for Disease Control & Prevention (CDC) in 2016, 23.6 million people suffered from diabetes, which is 7.8% of the total population in the U.S. One third of the diabetic population in the U.S also suffered from lower extremity wounds.
Moreover, according to the statistics published by Diabetes UK, in 2015, the prevalence of diabetic foot ulcers among diabetic population is estimated to be 2.5%, which accounted around 86,000 people in the U.K. Also, foot complications are the most common reason of hospitalization in the U.K. Furthermore, increasing prevalence of diabetes in China and India, is expected to create a conducive environment for the growth of this market in these countries. According to World Health Organization (WHO), the number of diabetic patients in India and China are expected to reach 79.4 million and 42.3 million, respectively, by 2030.
Ask for customization: https://www.coherentmarketinsights.com/insight/request-customization/1159
Also, according to the Diabetes journal, in 2014, the annual incidences of diabetes stood around 1–7%, globally. With the huge population base suffering from diabetes both in advanced and emerging markets, the advanced wound care management market is expected to witness robust growth rate in the forecast period (2017–2025).
However, high cost of products associated with the treatment of chronic wounds is one of the factor adversely affecting growth of the advanced wound care management market. According to report published by The College of Podiatric Medicine, in 2015, around 9%–20% of patients in the U.S with diabetic foot ulcers require hospitalization. Furthermore, it also stated that the cost of treatment of diabetic foot ulcers increases with age and duration.